Evaluation of the potential of a new ribavirin analog impairing the dissemination of ovarian cancer cells
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference41 articles.
1. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research;E Kipps;Nat Rev Cancer,2013
2. New strategies in the treatment of ovarian cancer: current clinical perspectives and future potential;S Banerjee;Clin Cancer Res Off J Am Assoc Cancer Res,2013
3. Ovarian surface epithelium: biology, endocrinology, and pathology;N Auersperg;Endocr Rev,2001
4. Focus on epithelial ovarian cancer;RF Ozols;Cancer Cell,2004
5. Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?;KLB Borden;Leuk Lymphoma,2010
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ribavirin in Modern Antitumor Therapy: Prospects for Intranasal Administration;Current Drug Delivery;2024-08-26
2. Development of an Intranasal In Situ System for Ribavirin Delivery: In Vitro and In Vivo Evaluation;Pharmaceutics;2024-08-26
3. Synthetic 1,2,4-triazole-3-carboxamides Induce Cell Cycle Arrest and Apoptosis in Leukemia Cells;Current Pharmaceutical Design;2023-12
4. C-Ribosylating Enzymes in the (Bio)Synthesis of C-Nucleosides and C-Glycosylated Natural Products;ACS Catalysis;2023-11-28
5. In Vitro Models of Ovarian Cancer: Bridging the Gap between Pathophysiology and Mechanistic Models;Biomolecules;2023-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3